share_log

赛升药业(300485.SZ):子公司君元药业药品生产许可证变更

Saisheng Pharmaceutical (300485.SZ): Change of pharmaceutical production license for subsidiary Junyuan Pharmaceutical

Gelonghui Finance ·  Feb 26 15:41

Gelonghui, Feb. 26 | Saisheng Pharmaceutical (300485.SZ) announced that its subsidiary Shenyang Junyuan Pharmaceutical Co., Ltd. (“Junyuan Pharmaceutical”) recently obtained a “Pharmaceutical Production License” issued by the Liaoning Provincial Drug Administration. The matters involved in this change are: it was agreed that the company would change the production site of Strong Kidney Tablets (Sinopharm standard Z21020715, each tablet weighs 0.3 g) from No. 6, Lane 103, Lingyun Street, Dongling District, Shenyang City to Building 9 and 22, No. 603, Maizitun, Hunnan District, Shenyang City. Other details remained unchanged.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment